Mark Towne serves as the Vice President of Information Technology at CooperSurgical, where he plays a pivotal role in shaping the company’s technological landscape to align with its ambitious growth and acquisition strategies. With a wealth of experience in the medical device, healthcare, and pharmaceutical...
Mark Towne serves as the Vice President of Information Technology at CooperSurgical, where he plays a pivotal role in shaping the company’s technological landscape to align with its ambitious growth and acquisition strategies. With a wealth of experience in the medical device, healthcare, and pharmaceutical sectors, Mark is dedicated to driving innovation through data and technology. He leads the transformational build and adoption of enterprise business processes, applications, and data capabilities, ensuring that CooperSurgical remains at the forefront of the life sciences industry.
Under Mark's leadership, the global IT organization has evolved into a high-performing team that leverages advanced analytics and business intelligence to enhance operational efficiency and customer engagement. His expertise in value engineering and product lifecycle management enables CooperSurgical to streamline processes and optimize resource allocation, ultimately enhancing the customer experience. Mark is passionate about fostering a culture of data-driven decision-making, empowering teams to harness the power of data analytics to inform strategies and drive business results.
Key projects under Mark’s guidance include the implementation of cutting-edge customer relationship management (CRM) systems and the integration of advanced data analytics platforms that provide actionable insights across the organization. By championing IT transformation initiatives, Mark is not only enhancing CooperSurgical's technological capabilities but also positioning the company for sustained growth in an increasingly competitive market. His visionary approach and commitment to excellence make him a driving force in the evolution of CooperSurgical as a leader in the life sciences sector.
